| Authors: |
Zhang X; Rubius Therapeutics, Inc., Cambridge, MA, USA., Luo M; Rubius Therapeutics, Inc., Cambridge, MA, USA., Dastagir SR; Rubius Therapeutics, Inc., Cambridge, MA, USA., Nixon M; Rubius Therapeutics, Inc., Cambridge, MA, USA., Khamhoung A; Rubius Therapeutics, Inc., Cambridge, MA, USA., Schmidt A; Rubius Therapeutics, Inc., Cambridge, MA, USA., Lee A; Rubius Therapeutics, Inc., Cambridge, MA, USA., Subbiah N; Rubius Therapeutics, Inc., Cambridge, MA, USA., McLaughlin DC; Rubius Therapeutics, Inc., Cambridge, MA, USA., Moore CL; Rubius Therapeutics, Inc., Cambridge, MA, USA., Gribble M; Rubius Therapeutics, Inc., Cambridge, MA, USA., Bayhi N; Rubius Therapeutics, Inc., Cambridge, MA, USA., Amin V; Rubius Therapeutics, Inc., Cambridge, MA, USA., Pepi R; Rubius Therapeutics, Inc., Cambridge, MA, USA., Pawar S; Rubius Therapeutics, Inc., Cambridge, MA, USA., Lyford TJ; Rubius Therapeutics, Inc., Cambridge, MA, USA., Soman V; Rubius Therapeutics, Inc., Cambridge, MA, USA., Mellen J; Rubius Therapeutics, Inc., Cambridge, MA, USA., Carpenter CL; Rubius Therapeutics, Inc., Cambridge, MA, USA., Turka LA; Rubius Therapeutics, Inc., Cambridge, MA, USA., Wickham TJ; Rubius Therapeutics, Inc., Cambridge, MA, USA., Chen TF; Rubius Therapeutics, Inc., Cambridge, MA, USA. tiffany.chen@rubiustx.com. |
